Overview

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). This is an in-patient trial investigating stepwise dose increase in a period of up to 3-weeks followed by a 10-week out-patient maintenance period. A telephone contact visit is scheduled as a follow-up for the final clinic visit. A subject's participation in this trial would be expected to be up to 16 weeks.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Aspart
Insulin, Globin Zinc